Skip to main content

News

News
09/08/2025
Pulse Biosciences, Inc., announced that the U.S. FDA has granted approval for the Company’s Investigational Device Exemption, allowing Pulse Biosciences to proceed with the initiation of its nsPFA Cardiac Surgery System Study, NANOCLAMP AF,...
Pulse Biosciences, Inc., announced that the U.S. FDA has granted approval for the Company’s Investigational Device Exemption, allowing Pulse Biosciences to proceed with the initiation of its nsPFA Cardiac Surgery System Study, NANOCLAMP AF,...
Pulse Biosciences, Inc.,...
09/08/2025
EP Lab Digest
Mitral Valve Intervention
09/08/2025
The Sutra Hemi-valve™ is a novel posterior leaflet replacement technology designed to restore mitral valve function without obstructing the left ventricular outflow tract.
The Sutra Hemi-valve™ is a novel posterior leaflet replacement technology designed to restore mitral valve function without obstructing the left ventricular outflow tract.
The Sutra Hemi-valve™ is a novel...
09/08/2025
Cath Lab Digest